Assessment of clinical trial participation on breast cancer survival

被引：0
|
作者：
Parise, C. [1 ]
Caggiano, V. [1 ]
机构：
[1] Sutter Inst Med Res, Sacramento, CA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P4-10-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-10-04
引用
收藏
页数：2
相关论文
共 50 条
  • [21] BREAST CANCER SURVIVAL IN GALICIA BASED ON PARTICIPATION IN THE SCREENING PROGRAM
    Pazos-Espanol, P.
    Santiago-Perez, M. I.
    Naveira-Barbeito, G.
    Crujeiras-Casais, R. M.
    Tarrazo-Antelo, A. M.
    Corujo-Quinteiro, M.
    Gomez-Amorin, A.
    Malvar-Pintos, A.
    GACETA SANITARIA, 2023, 37 : S155 - S155
  • [22] Impact of clinical trial participation on the survival of patients with newly diagnosed advanced-stage ovarian cancer
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eunji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A190 - A191
  • [23] Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer
    Merkhofer, Cristina M.
    Eaton, Keith D.
    Martins, Renato G.
    Ramsey, Scott D.
    Goulart, Bernardo H. L.
    CLINICAL LUNG CANCER, 2021, 22 (06) : 523 - 530
  • [24] Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer
    Morton, Molly
    Yao, Meng
    Chalif, Julia
    Lampert, Erika J.
    Chau, Danielle
    Rose, Peter G.
    Debernardo, Robert
    Michener, Chad M.
    Vargas, Roberto
    Chambers, Laura M.
    OBSTETRICS AND GYNECOLOGY, 2023, 142 (03): : 459 - 466
  • [25] Impact of clinical trial participation on the survival of patients with newly diagnosed advanced-stage ovarian cancer
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A383 - A383
  • [26] The impact of clinical trial participation on overall survival in advanced ovarian cancer patients at a single-institution cancer center
    Mallen, A. R.
    Boac, B. M.
    Todd, S. L.
    Xiong, Y.
    Magliocco, A.
    Chon, H. S.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 212 - 213
  • [27] Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial
    Loehberg, Christian R.
    Jud, Sebastian M.
    Haeberle, Lothar
    Heusinger, Katharina
    Dilbat, Gerhard
    Hein, Alexander
    Rauh, Claudia
    Dall, Peter
    Rix, Nadine
    Heinrich, Sabrina
    Buchholz, Stefan
    Lex, Benno
    Reichler, Barbara
    Adamietz, Boris
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Fasching, Peter A.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (01) : 101 - 110
  • [28] Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial
    Christian R. Loehberg
    Sebastian M. Jud
    Lothar Haeberle
    Katharina Heusinger
    Gerhard Dilbat
    Alexander Hein
    Claudia Rauh
    Peter Dall
    Nadine Rix
    Sabrina Heinrich
    Stefan Buchholz
    Benno Lex
    Barbara Reichler
    Boris Adamietz
    Ruediger Schulz-Wendtland
    Matthias W. Beckmann
    Peter A. Fasching
    Breast Cancer Research and Treatment, 2010, 121 : 101 - 110
  • [29] Patient Income Level and Cancer Clinical Trial Participation
    Unger, Joseph M.
    Hershman, Dawn L.
    Albain, Kathy S.
    Moinpour, Carol M.
    Petersen, Judith A.
    Burg, Kenda
    Crowley, John J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) : 536 - 542
  • [30] Patient comorbid conditions and cancer clinical trial participation
    Unger, Joseph M.
    Hershman, Dawn L.
    Fleury, Mark
    Vaidya, Riha
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345